Vitalstoffe 4/2021

V italstoffe
cil on Clinical Cardiology. Seafood
Long-Chain n-3 Polyunsaturated Fatty
Acids and Cardiovascular Disease:
A Science Advisory From the American
Heart Association. Circulation.
2018;138(1):e35-e47
(31) Mozaffarian D, Lemaitre RN, King
IB, Song X, Spiegelman D, Sacks FM, et
al. Circulating long-chain omega-3 fatty
acids and incidence of congestive heart
failure in older adults: the cardiovascular
health study: a cohort study. Ann
Intern Med. 2011;155(3):160-70.
(32) Tavazzi L, Maggioni AP, Marchioli
R, Barlera S, Franzosi mg, Latini
Ret al; Gissi-HF Investigators. Effect
of n-3 polyunsaturated fatty acids in
patients with chronic heart failure (the
GISSI-HF trial): a randomised, doubleblind,
placebo-controlled trial. Lancet.
2008;372(9645):1223-30.
(33) Barbarawi M, Lakshman H,
Barbarawi O, Alabdouh A, Al Kasasbeh
M, Djousse L, Manson JE. Omega-3
supplementation and heart failure: A
meta-analysis of 12 trials including
81,364 participants. Contemp Clin
Trials. 2021;107:106458.
(34) Ponikowski P, Voors AA, Anker SD,
Bueno H, Cleland JGF, Coats AJS, et al;
ESC Scientific Document Group. 2016
ESC Guidelines for the diagnosis and
treatment of acute and chronic heart
failure: The Task Force for the diagnosis
and treatment of acute and chronic
heart failure of the European Society of
Cardiology (ESC)Developed with the
special contribution of the Heart Failure
Association (HFA) of the ESC. Eur
Heart J. 2016;37(27):2129-200.
(35) McDonagh TA, Metra M, Adamo
M, et al; ESC Scientific Document
Group. 2021 ESC Guidelines for the
diagnosis and treatment of acute and
chronic heart failure. Eur Heart J. 2021
Aug 27:ehab368.
(36) Cowie MR, Cure S, Bianic F,
McGuire A, Goodall G, Tavazzi L.
Cost-effectiveness of highly purified
omega-3 polyunsaturated fatty acid
ethyl esters in the treatment of chronic
heart failure: results of Markov modelling
in a UK setting. Eur J Heart Fail.
2011;13(6):681-9
(37) Lechner K, Scherr J, Lorenz E, et
al. Omega-3 fatty acid blood levels are
inversely associated with cardiovascular
risk factors in HFpEF patients: the
Aldo-DHF randomized controlled trial.
Clin Res Cardiol 2021, e-pub Aug 28
(38) Marchioli R, Barzi F, Bomba E,
Chieffo C, Di Gregorio D, Di Mascio R,
et al; GISSI-Prevenzione Investigators.
Early protection against sudden death
by n-3 polyunsaturated fatty acids after
myocardial infarction: time-course
analysis of the results of the Gruppo Italiano
per lo Studio della Sopravvivenza
nell‘Infarto Miocardico (GISSI)-Prevenzione.
Circulation. 2002;105(16):1897-
903.
(39) Priori SG, Blomström-Lundqvist
C, Mazzanti A, Blom N, Borggrefe M,
Camm J, et al; ESC Scientific Document
Group. 2015 ESC Guidelines for the
management of patients with ventricular
arrhythmias and the prevention of sudden
cardiac death: The Task Force for
the Management of Patients with Ventricular
Arrhythmias and the Prevention of
Sudden Cardiac Death of the European
Society of Cardiology (ESC). Endorsed
by: Association for European Paediatric
and Congenital Cardiology (AEPC).
Eur Heart J. 2015;36(41):2793-867.
(40) Al-Khatib SM, Stevenson WG,
Ackerman MJ, Bryant WJ, Callans DJ,
Curtis AB, et al. 2017 AHA/ACC/HRS
Guideline for Management of Patients
With Ventricular Arrhythmias and the
Prevention of Sudden Cardiac Death:
A Report of the American College of
Cardiology/American Heart Association
Task Force on Clinical Practice Guidelines
and the Heart Rhythm Society.
Circulation. 2018;138(13):e272-e391
(41) von Schacky C. Omega-3 Fatty
Acids in Pregnancy – the case for
a target Omega-3-Index. Nutrients
2020;12:898
(42) Mocellin MC, Fernandes R,
Chagas TR, Trindade EBSM. A metaanalysis
of n-3 polyunsaturated fatty
acids effects on circulating acute-phase
protein and cytokines in gastric cancer.
Clin Nutr. 2018;37(3):840-50.
(43) Lee CH, Fu Y, Yang SJ, Chi CC.
Effects of Omega-3 Polyunsaturated
Fatty Acid Supplementation on Non-
Alcoholic Fatty Liver: A Systematic
Review and Meta-Analysis. Nutrients.
2020;12:2769.
(44) von Schacky C. Omega-3-Fettsäuren
– Spiegel rauf im Leistungssport.
Sportärztezeitung 2018
(45) Jia X, Gao F, Pickett JK, Al Rifai
M, Birnbaum Y, Nambi V, et al. Association
Between Omega-3 Fatty Acid Treatment
and Atrial Fibrillation in Cardiovascular
Outcome Trials: A Systematic
Review and Meta-Analysis. Cardiovasc
Drugs Ther. 2021;35(4):793-800
(46) Metcalf RG, Skuladottir GV, Indridason
OS, Sullivan TR, Bjorgvinsdottir
L, Sanders P, et al. U-shaped relationship
between tissue docosahexaenoic
acid and atrial fibrillation following
cardiac surgery. Eur J Clin Nutr.
2014;68(1):114-8
Autor:
Professor Dr. Clemens von Schacky,
Kardiologe, Erfinder des HS-Omega-
3-Index, war Chefarzt für Kardiologie,
Leiter der präventiven Kardiologie an
der LMU München.
48